Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02829723 |
Title | Phase I/II Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ITA | ISR | ESP | CHE |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Dana Farber Cancer Institute Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Sarah Cannon Research Institute Sarah Cannon Research | Nashville | Tennessee | 37203 | United States | Details | |
UT M.D Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Mays Cancer Ctr Uthsa Mdacc | San Antonio | Texas | 78229 | United States | Details | |
Novartis Investigative Site | Tel Aviv | 6423906 | Israel | Details | ||
Novartis Investigative Site | Rozzano | MI | 20089 | Italy | Details | |
Novartis Investigative Site | Nagoya | Aichi | 466 8560 | Japan | Details | |
Novartis Investigative Site | Koto ku | Tokyo | 135 8550 | Japan | Details | |
Novartis Investigative Site | Singapore | 168583 | Singapore | Details | ||
Novartis Investigative Site | Barcelona | Catalunya | 08035 | Spain | Details | |
Novartis Investigative Site | Hospitalet de LLobregat | Catalunya | 08907 | Spain | Details | |
Novartis Investigative Site | Madrid | 28041 | Spain | Details | ||
Novartis Investigative Site | Zurich | 8091 | Switzerland | Details | ||
Novartis Investigative Site | Taipei | 10002 | Taiwan | Details |